![Clene Inc](/common/images/company/N_CLNN.png)
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more
LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) -- Β via IBN β IBN, a multifaceted communications organization engaged in connecting public companies with the investment community, today announces...
LOS ANGELES, March 19, 2024 (GLOBE NEWSWIRE) -- via IBN β IBN, a multifaceted communications organization engaged in connecting public companies with the investment community, today announces...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0574 | -16.5656565657 | 0.3465 | 0.35 | 0.285 | 320091 | 0.33489519 | CS |
4 | -0.1409 | -32.7674418605 | 0.43 | 0.449399 | 0.285 | 490360 | 0.37785144 | CS |
12 | -0.0448 | -13.4171907757 | 0.3339 | 0.46 | 0.285 | 898709 | 0.35712171 | CS |
26 | -0.0609 | -17.4 | 0.35 | 0.55 | 0.285 | 785259 | 0.39505255 | CS |
52 | -0.5209 | -64.3086419753 | 0.81 | 0.8499 | 0.25 | 696666 | 0.4237317 | CS |
156 | -10.6509 | -97.3574040219 | 10.94 | 17.82 | 0.25 | 569690 | 2.23183959 | CS |
260 | -9.2609 | -96.9727748691 | 9.55 | 17.82 | 0.25 | 514785 | 2.79279232 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.